Oct 2024 $22 M No. 5 $10 to $50 million 12
Cellular Longevity, Inc.: Raise no. 5, Oct 2024 × Investors in this round 12 investors had bought by the notice of Oct 28, 2024: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $22 M of $33 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Celine-Lea Halioua-Haubold · Executive Officer, Director Blake Scholl · Director Kevin Zhang · Director Laura Deming · Director Linda Rhodes · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount and Total Amount Sold include conversion of the previously issued Simple Agreements for Future Equity”Signed by Celine-Lea Halioua-Haubold, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 28, 2024. Read the notice at the SEC .
equity SEC Mar 2024 $76 M No. 4 $50 to $250 million 38
Cellular Longevity, Inc.: Raise no. 4, Mar 2024 × Investors in this round 38 investors had bought by the notice of Mar 29, 2024: 38 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $76 M of $76 M offered
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Celine-Lea Halioua-Haubold · Executive Officer, Director Blake Scholl · Director Kevin Zhang · Director Laura Deming · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Offering and Sales Amount inclusive of converting SAFEs.”Signed by Celine-Lea Halioua-Haubold, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 29, 2024. Read the notice at the SEC .
equity SEC Aug 2021 $28 M No. 3 $10 to $50 million 42
Cellular Longevity, Inc.: Raise no. 3, Aug 2021 × Investors in this round 42 investors had bought by the notice of Oct 1, 2021: 42 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $28 M of $29 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Series A Preferred Stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Celine-Lea Halioua-Haubold · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes the conversion of certain SAFEs”On the use of proceeds: “Some of the proceeds may be used for general working capital purposes, including the payment of salaries and other fees to those listed in Item 3.”Signed by Celine-Lea Halioua-Haubold, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 1, 2021. Read the notice at the SEC .
equity SEC Sep 2020 $5 M No. 2 $2 to $10 million 28
Cellular Longevity, Inc.: Raise no. 2, Sep 2020 × Investors in this round 28 investors had bought by the notice of Jun 25, 2021: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Celine-Lea Halioua-Haubold · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Celine-Lea Halioua-Haubold, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 25, 2021. Read the notice at the SEC .
equity SEC Jan 2020 $5 M No. 1 $2 to $10 million 19
Cellular Longevity, Inc.: Raise no. 1, Jan 2020 × Investors in this round 19 investors had bought by the notice of Jan 16, 2020: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Celine-Lea Halioua-Haubold · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Celine-Lea Halioua-Haubold, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 16, 2020. Read the notice at the SEC .
equity SEC